Home›Gastroenterology› Six amino acid metabolism biomarkers distinguish periodontitis from controls in early in silico and tissue validation
Six amino acid metabolism biomarkers distinguish periodontitis from controls in early in silico and tissue validationNew biomarkers may help identify and track gum disease
Frontiers in MedicinePublished October 28, 2026DOI ↗Editorial oversight: Dr. Amelia Tan, PhD · Internal Medicine & Chronic Disease
AI-generated summary of the cited source, checked by automated accuracy review.
How we work
Share
Key Takeaway
Interpret these six biomarkers as exploratory; external validation is needed before clinical use.
This publication reports an in silico analysis with experimental validation aimed at identifying amino acid metabolism-related diagnostic biomarkers for periodontitis. The work combines bulk transcriptomic datasets, single-cell RNA sequencing, consensus clustering, immune infiltration analysis, cell-cell communication, and pseudotime analysis, with validation in human gingival tissue samples.
The authors identified six amino acid metabolism-related biomarkers: TDO2, ICAM2, VWF, FABP4, ACAT2, and AHNAK2. TDO2, ICAM2, VWF, and FABP4 were upregulated in periodontitis, while ACAT2 and AHNAK2 were downregulated. A six-gene nomogram discriminated periodontitis from controls with an AUC of 0.956 in the GSE16134 dataset. Single-cell analysis showed the highest biomarker activity in endothelial cells, which also had the strongest diagnostic biomarker module score. Experimental validation confirmed changes at both mRNA and protein levels for TDO2, ICAM2, VWF, FABP4, and ACAT2 in clinical samples.
The authors note that cross-platform evaluation revealed calibration limitations. No safety or adverse event data are reported, and follow-up duration is not reported. Certainty of evidence is not reported.
The findings provide an immune-metabolic framework for biomarker development and mechanistic studies in periodontitis, but the diagnostic performance requires validation in independent, prospectively collected cohorts before any clinical application.
How this fits prior evidence
This biomarker work extends prior coverage of periodontitis as a condition with systemic associations, including links to genitourinary susceptibility, Parkinson's disease, and oral health-related quality of life in ESRD. Unlike prior coverage of antimicrobial photodynamic therapy, which showed negligible clinical improvement, this report focuses on molecular diagnostic candidates rather than treatment. The identification of six amino acid metabolism-related biomarkers and an AUC of 0.956 in one dataset adds a mechanistic, immune-metabolic dimension to the periodontal literature already covered, but it does not confirm causality or clinical utility.
Periodontitis is more than just a dental issue; it involves complex immune responses and metabolism. Researchers used a mix of computer modeling and lab testing to find a way to better identify this condition. They focused on how the body processes amino acids, which are the building blocks of protein, to find specific signals of disease.
They identified six specific markers: TDO2, ICAM2, VWF, and FABP4 went up in patients with periodontitis, while ACAT2 and AHNAK2 went down. These markers were confirmed at both the mRNA and protein levels in clinical samples. The study also found that these markers are most active in endothelial cells, which are the cells that line your blood vessels.
While the results show a strong way to distinguish between healthy and diseased tissue, the study notes some limitations. Specifically, the researchers found some calibration issues when comparing different testing platforms. These findings provide a new framework for understanding how the immune system and metabolism interact during gum disease.
What this means for you:
Six specific amino acid markers could provide a clearer way to diagnose and track periodontitis.
Common questions
What are the specific markers found for periodontitis?
The study identified six amino acid metabolism-related biomarkers. TDO2, ICAM2, VWF, and FABP4 were found to be higher in people with periodontitis, while ACAT2 and AHNAK2 were lower. These markers were confirmed at both the mRNA and protein levels in clinical samples.
How accurate are these markers at identifying the disease?
The study used a nomogram, which is a predictive tool, to test these six genes. The tool showed a high level of accuracy, with an AUC of 0.956, in distinguishing between periodontitis and healthy controls.
Where in the body are these markers most active?
Single-cell analysis showed that the highest activity for these biomarkers was located in endothelial cells. These are the cells that line your blood vessels, and they showed the strongest scores for the diagnostic biomarker module.
BackgroundPeriodontitis (PD) is a chronic inflammatory disease driven by microbial dysbiosis and immune-mediated periodontal tissue destruction. Although amino acid metabolic dysregulation has been implicated in inflammatory diseases, its diagnostic relevance and cellular context in PD remain unclear. We aimed to identify amino acid metabolism-related diagnostic biomarkers and characterize their potential roles in PD.MethodsBulk transcriptomic datasets (GSE16134, GSE10334, and GSE223924) and a single-cell RNA sequencing dataset (GSE164241) were analyzed. Amino acid metabolism-related differentially expressed genes were identified and functionally annotated through enrichment analyses. LASSO regression, Boruta, and random forest jointly screened diagnostic biomarkers. A nomogram was constructed and assessed by ROC, calibration, and decision curve analyses. Immune infiltration, consensus clustering, and weighted gene co-expression network analysis were performed; cell-type localization, cell-cell communication, and pseudotime analyses used single-cell data. Human gingival tissue samples were used for validation through histological analysis, immunohistochemistry, and quantitative real-time PCR (RT-qPCR).ResultsSix amino acid metabolism-related biomarkers showed concordant expression changes across the three bulk datasets. TDO2, ICAM2, VWF and FABP4 were upregulated in periodontitis, whereas ACAT2 and AHNAK2 were downregulated. The six-gene nomogram discriminated PD from controls in GSE16134 (AUC = 0.956), while cross-platform evaluation revealed calibration limitations. Enrichment analysis linked these biomarkers to chemokine and cytokine signaling, cell adhesion and leukocyte transendothelial migration. Immune infiltration and consensus clustering revealed broad immune associations and three expression-based subgroups with distinct inflammatory features. Single-cell analysis localized the highest biomarker activity to endothelial cells, which showed the strongest diagnostic biomarker module score despite a relative reduction in their proportion. Pseudotime analysis revealed biomarker expression variation along an inferred endothelial trajectory, while CellChat predicted altered endothelial–immune communication. Experimental validation confirmed these changes for TDO2, ICAM2, VWF, FABP4 and ACAT2 at both mRNA and protein levels in clinical samples.ConclusionWe identify six amino acid metabolism-related candidate biomarkers with diagnostic potential for PD—five supported by clinical gingival tissue expression data—and link them to endothelial cell state changes and immune microenvironment remodeling. These findings provide an immune-metabolic framework for biomarker development and mechanistic studies in PD.
